MASLD and Liver Cancer: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where too much fat builds up in your liver. Unlike fatty liver caused by heavy ...

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking ...

A surprising new study reveals that blocking a supposedly protective enzyme, Caspase-2, could actually backfire—raising the risk of chronic liver damage and cancer over time. Researchers found that ...

Neuroendocrine liver cancer develops in cells that produce hormones in response to nerve signals. Most neuroendocrine liver cancers spread from other organs. Liver cancer accounts for more than ...

The treatment plan for liver cancer can vary depending on the stage, size, and location of the tumor. Common options include surgery, ablation, cryotherapy, immunotherapy, and targeted drug therapy.

Liver cancer develops when cells in the liver grow or reproduce uncontrollably. When they become particularly advanced or aggressive, they can spread to other organs. Healthcare professionals consider ...

Early detection has the potential to transform treatment and outcomes in cancer care, especially for cancers like liver cancer, which is typically diagnosed at a late stage with limited options for ...

Most types of chemotherapy cannot cure liver cancer, but combining chemotherapy and other drugs may help shrink liver tumors. Some approaches may help a person live longer. Chemotherapy can be a ...

A new study suggests that Resmetirom may do more than treat fatty liver disease — it could also help stop liver cancer from ...

Margot got the news in her early 20s: "You have liver cancer," her doctors told her. Specifically, Margot had a form of liver cancer known as fibrolamellar carcinoma, a diagnosis with deadly prospects ...